Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)
PHASE1
This is a randomized, double-blind, double-dummy, placebo- and active-contr...
A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD)
PHASE1
The main purpose of this study is to determine the rate and extent of absor...
Status
Completed
Location
Saskatoon Centre for Patient-Oriented Research, Royal University Hospital, Room 5681, C Wing